Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Allison Bratzel's Stock Ratings
Piper Sandler Analyst
Allison Bratzel is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/04/2025
Overall Average Return
15.1%
Smart Score
Overall Average Return Percentile
74th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/17/2025 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.30 | 192.62% | Allison Bratzel68% | $140 → $115 | Maintains | Overweight | Get Alert |
| 03/14/2025 | AKBA | Buy Now | Akebia Therapeutics | $2.43 | 146.91% | Allison Bratzel68% | $4 → $6 | Maintains | Overweight | Get Alert |
| 03/11/2025 | INZY | Buy Now | Inozyme Pharma | $1.55 | 1383.78% | Allison Bratzel68% | $30 → $23 | Maintains | Overweight | Get Alert |
| 02/18/2025 | ENGN | Buy Now | enGene Holdings | $3.85 | 575.32% | Allison Bratzel68% | → $26 | Initiates | → Overweight | Get Alert |
| 01/07/2025 | ARGX | Buy Now | argenx | $649.67 | 11.6% | Allison Bratzel68% | $620 → $725 | Maintains | Overweight | Get Alert |
| 11/14/2024 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 4.02% | Allison Bratzel68% | $12 → $22 | Maintains | Neutral | Get Alert |
| 11/14/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $19.36 | 18.8% | Allison Bratzel68% | $15 → $23 | Maintains | Neutral | Get Alert |
| 11/14/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 87.25% | Allison Bratzel68% | $65 → $62 | Maintains | Overweight | Get Alert |
| 11/01/2024 | ARGX | Buy Now | argenx | $649.67 | -4.57% | Allison Bratzel68% | $553 → $620 | Maintains | Overweight | Get Alert |
| 10/15/2024 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | 27.62% | Allison Bratzel68% | $28 → $42 | Maintains | Overweight | Get Alert |
| 08/02/2024 | TVTX | Buy Now | Travere Therapeutics | $21.15 | -43.26% | Allison Bratzel68% | $11 → $12 | Maintains | Neutral | Get Alert |
| 07/10/2024 | ROIV | Buy Now | Roivant Sciences | $11.48 | 91.64% | Allison Bratzel68% | $20 → $22 | Maintains | Overweight | Get Alert |
| 06/24/2024 | ARGX | Buy Now | argenx | $649.67 | -17.65% | Allison Bratzel68% | $522 → $535 | Maintains | Overweight | Get Alert |
| 06/17/2024 | ARGX | Buy Now | argenx | $649.67 | -19.65% | Allison Bratzel68% | $522 → $522 | Maintains | Overweight | Get Alert |
| 03/26/2024 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | -14.92% | Allison Bratzel68% | → $28 | Maintains | Overweight | Get Alert |
| 03/26/2024 | HUMA | Buy Now | Humacyte | $1.30 | 207.69% | Allison Bratzel68% | $4 → $4 | Maintains | Neutral | Get Alert |
| 03/14/2024 | SLDB | Buy Now | Solid Biosciences | $4.31 | 364.04% | Allison Bratzel68% | $8 → $20 | Upgrade | Neutral → Overweight | Get Alert |
| 03/08/2024 | HUMA | Buy Now | Humacyte | $1.30 | 207.69% | Allison Bratzel68% | $3 → $4 | Maintains | Neutral | Get Alert |
| 01/26/2024 | ARGX | Buy Now | argenx | $649.67 | -19.65% | Allison Bratzel68% | $518 → $522 | Maintains | Overweight | Get Alert |
| 01/18/2024 | ARGX | Buy Now | argenx | $649.67 | -20.27% | Allison Bratzel68% | $515 → $518 | Maintains | Overweight | Get Alert |
| 01/05/2024 | ROIV | Buy Now | Roivant Sciences | $11.48 | 74.22% | Allison Bratzel68% | → $20 | Initiates | → Overweight | Get Alert |
| 12/21/2023 | ARGX | Buy Now | argenx | $649.67 | -20.73% | Allison Bratzel68% | $575 → $515 | Maintains | Overweight | Get Alert |
| 10/13/2023 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 729.84% | Allison Bratzel68% | → $20 | Assumes | → Overweight | Get Alert |
| 08/31/2023 | ARGX | Buy Now | argenx | $649.67 | -7.65% | Allison Bratzel68% | $595 → $600 | Maintains | Overweight | Get Alert |
| 07/24/2023 | ARGX | Buy Now | argenx | $649.67 | -11.49% | Allison Bratzel68% | $545 → $575 | Maintains | Overweight | Get Alert |
| 04/20/2023 | VECT | Buy Now | VectivBio Holding | — | — | Allison Bratzel68% | $23 → $25 | Maintains | Overweight | Get Alert |
| 04/17/2023 | REPL | Buy Now | Replimune Group | $10.01 | 339.56% | Allison Bratzel68% | → $44 | Assumes | → Overweight | Get Alert |
| 04/03/2023 | RIGL | Buy Now | Rigel Pharmaceuticals | $19.36 | -89.67% | Allison Bratzel68% | → $20 | Assumes | → Neutral | Get Alert |
| 04/03/2023 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | -21% | Allison Bratzel68% | → $26 | Assumes | → Overweight | Get Alert |
| 02/23/2023 | ARGX | Buy Now | argenx | $649.67 | -26.89% | Allison Bratzel68% | $465 → $475 | Maintains | Overweight | Get Alert |
| 02/08/2023 | INCY | Buy Now | Incyte | $59.41 | 68.32% | Allison Bratzel68% | → $100 | Maintains | Overweight | Get Alert |
| 01/31/2023 | INCY | Buy Now | Incyte | $59.41 | 68.32% | Allison Bratzel68% | → $100 | Initiates | → Overweight | Get Alert |
| 11/11/2022 | SLDB | Buy Now | Solid Biosciences | $4.31 | 85.61% | Allison Bratzel68% | $15 → $8 | Maintains | Neutral | Get Alert |
| 08/26/2022 | ARGX | Buy Now | argenx | $649.67 | -28.43% | Allison Bratzel68% | $450 → $465 | Maintains | Overweight | Get Alert |
| 07/25/2022 | ARGX | Buy Now | argenx | $649.67 | -34.58% | Allison Bratzel68% | $415 → $425 | Maintains | Overweight | Get Alert |
| 05/27/2022 | ARGX | Buy Now | argenx | $649.67 | -36.12% | Allison Bratzel68% | $375 → $415 | Maintains | Overweight | Get Alert |
| 05/19/2022 | SLDB | Buy Now | Solid Biosciences | $4.31 | -53.6% | Allison Bratzel68% | $75 → $30 | Maintains | Neutral | Get Alert |
| 04/28/2022 | SLDB | Buy Now | Solid Biosciences | $4.31 | 16.01% | Allison Bratzel68% | $90 → $75 | Maintains | Neutral | Get Alert |
